d*r
2 楼
RNA一大早跌了80%..
http://www.businessweek.com/news/2013-09-20/prosensa-shares-plu
Bloomberg News
Prosensa Shares Plunge as Muscular Dystrophy Drug Fails in Trial
By Makiko Kitamura September 20, 2013
Prosensa Holding NV (RNA:US) plunged after the Dutch company’s experimental
muscular dystrophy drug failed to help patients walk better in a clinical
trial.
Prosensa sank 71 percent to $7 at 7:55 a.m. New York time in trading (RNA:US
) before U.S. exchanges opened. The company is based in Leiden, the
Netherlands, and listed on the Nasdaq Stock Market. Prosensa is developing
the treatment, drisapersen, with GlaxoSmithKline Plc. (GSK)
Drisapersen failed to help patients more than a placebo in a test of six-
minute walking distance, the companies said in a statement today.
STORY: Former Lehman CFO Erin Callan's Never Going Back
Duchenne muscular dystrophy is a neuromuscular disease with no known cure
that affects one in 3,500 newborn boys.
Glaxo rose 0.1 percent to 1,578 pence in London. Sarepta Therapeutics Inc.
is developing a competing drug.
Prosensa sold shares in June in an initial public offering (RNA:US) at $13
each. The company had a market value of $840.1 million based on yesterday’s
closing share price of $24.
http://www.businessweek.com/news/2013-09-20/prosensa-shares-plu
Bloomberg News
Prosensa Shares Plunge as Muscular Dystrophy Drug Fails in Trial
By Makiko Kitamura September 20, 2013
Prosensa Holding NV (RNA:US) plunged after the Dutch company’s experimental
muscular dystrophy drug failed to help patients walk better in a clinical
trial.
Prosensa sank 71 percent to $7 at 7:55 a.m. New York time in trading (RNA:US
) before U.S. exchanges opened. The company is based in Leiden, the
Netherlands, and listed on the Nasdaq Stock Market. Prosensa is developing
the treatment, drisapersen, with GlaxoSmithKline Plc. (GSK)
Drisapersen failed to help patients more than a placebo in a test of six-
minute walking distance, the companies said in a statement today.
STORY: Former Lehman CFO Erin Callan's Never Going Back
Duchenne muscular dystrophy is a neuromuscular disease with no known cure
that affects one in 3,500 newborn boys.
Glaxo rose 0.1 percent to 1,578 pence in London. Sarepta Therapeutics Inc.
is developing a competing drug.
Prosensa sold shares in June in an initial public offering (RNA:US) at $13
each. The company had a market value of $840.1 million based on yesterday’s
closing share price of $24.
x*n
3 楼
我上上周team member说马上安排onsite，结果上周没消息，这周到现在还没消息。
f*i
4 楼
我想明天厚着脸皮再打个电话问一下，唉。。。
【在 x*********n 的大作中提到】
: 我上上周team member说马上安排onsite，结果上周没消息，这周到现在还没消息。
【在 x*********n 的大作中提到】
: 我上上周team member说马上安排onsite，结果上周没消息，这周到现在还没消息。
x*n
5 楼
其实无所谓，我打算这周末快下班的时候问一下。
大公司的HR是挺忙的，每个人负责几十个岗位。我是因为安排phone interview很拖，
所以我估计onsite这么慢也是正常的。
【在 f******i 的大作中提到】
: 我想明天厚着脸皮再打个电话问一下，唉。。。
大公司的HR是挺忙的，每个人负责几十个岗位。我是因为安排phone interview很拖，
所以我估计onsite这么慢也是正常的。
【在 f******i 的大作中提到】
: 我想明天厚着脸皮再打个电话问一下，唉。。。
w*x
6 楼
明天问吧，表现得积极一点。good luck。
f*i
7 楼
打电话问了HR，说还没有安排，又给HM发了邮件骚扰，继续漫长的等待。。。
我人生中最美好的时间都在等待中过去了。。。
我人生中最美好的时间都在等待中过去了。。。
相关阅读
我的直觉告诉我，bsun这辟谣贴一发，张部长那里要炸锅4年，5年，6年phdTom Duke, 1964-2012Oncogene 封 jiaoshougege 在 Biology 版Re: 如果你是傅瑾，文凭是真的，会公示吗？ (转载)如果可以选择的话，大家会选择做自己擅长的事，还是自己喜欢的事付谨的nature要是造假的话说明什么？大家不用再纠缠中科大这件事了Oncogene 封 xiaoman0521 在 Biology 版根据报道，厦大傅瑾是伪造公文，根本不是医学本科生能不能当教授的问题Help for paper学位证书出来了 (转载)凭啥方舟子要人家亮出学位证？用大鼠细胞制造硅胶水母本科生造假最容易Anyone applied and heard back from Mbl stem cell and regeneration biology course?急救 退学大家觉得JBC和PLoS哪个更难投？分子调控领域中组部启动“万人计划”生物版竟然还有人反对舟子打傅谨